![Teva presenta Risedronato 75 mg, un cómodo y sencillo fármaco de administración mensual frente a la osteoporosis Teva presenta Risedronato 75 mg, un cómodo y sencillo fármaco de administración mensual frente a la osteoporosis](http://www.pmfarma.es/noticias/noticias/15421/image/RISEDRONATO-75.jpg)
Teva presenta Risedronato 75 mg, un cómodo y sencillo fármaco de administración mensual frente a la osteoporosis
![WO2009034580A1 - Improved process for the preparation of risedronate sodium hemipentahydrate - Google Patents WO2009034580A1 - Improved process for the preparation of risedronate sodium hemipentahydrate - Google Patents](https://patentimages.storage.googleapis.com/c3/c3/cb/2b238fd90d5ef2/imgf000005_0001.png)
WO2009034580A1 - Improved process for the preparation of risedronate sodium hemipentahydrate - Google Patents
![PDF) Bisphosphonates use and oral surgery : prevention and treatment of the Bisphosphonates-related Osteonecrosis of the Jaw PDF) Bisphosphonates use and oral surgery : prevention and treatment of the Bisphosphonates-related Osteonecrosis of the Jaw](https://www.researchgate.net/profile/Isabella-Bignozzi/publication/235009331/figure/fig2/AS:393516464263171@1470833044194/figure-fig2_Q320.jpg)
PDF) Bisphosphonates use and oral surgery : prevention and treatment of the Bisphosphonates-related Osteonecrosis of the Jaw
![PDF) Bisphosphonates use and oral surgery : prevention and treatment of the Bisphosphonates-related Osteonecrosis of the Jaw PDF) Bisphosphonates use and oral surgery : prevention and treatment of the Bisphosphonates-related Osteonecrosis of the Jaw](https://i1.rgstatic.net/publication/235009331_Bisphosphonates_use_and_oral_surgery_prevention_and_treatment_of_the_Bisphosphonates-related_Osteonecrosis_of_the_Jaw/links/02bfe510615ffd3f10000000/largepreview.png)